Table 1.

Inactivation of T Cells in Platelet Concentrates by Photochemical Treatment With 150 μmol/L S-59 and UVA Light (N = 4)

ReplicateNumber of Leukocytes per mL*T-Cell FrequencyLog10-Reduction of Viable T Cells-153
fcontrol-151ftreated-152
1.5 × 106 1/22  <1/1.1 × 107 >5.70  
1.3 × 106 1/41  <1/1.1 × 107 >5.43  
4.8 × 105 1/43  <1/1.1 × 107 >5.41  
3.4 × 106 1/110 <1/1.1 × 107 >5.00  
Mean  ± SD 1.7 ± 1.2 × 106 1/39 ± 1/67 <1/1.1 × 107 >5.39 ± 0.29 
ReplicateNumber of Leukocytes per mL*T-Cell FrequencyLog10-Reduction of Viable T Cells-153
fcontrol-151ftreated-152
1.5 × 106 1/22  <1/1.1 × 107 >5.70  
1.3 × 106 1/41  <1/1.1 × 107 >5.43  
4.8 × 105 1/43  <1/1.1 × 107 >5.41  
3.4 × 106 1/110 <1/1.1 × 107 >5.00  
Mean  ± SD 1.7 ± 1.2 × 106 1/39 ± 1/67 <1/1.1 × 107 >5.39 ± 0.29 

*PBMCs isolated from whole blood were spiked into each of four single donor plateletpheresis units in 300 mL of 35% autologous plasma and 65% PASIII to obtain final leukocyte counts that ranged between 4.8 × 105 and 3.4 × 106 per mL. An aliquot was withdrawn from each unit for measurement of the control viable T-cell frequency by the LDA assay as described in Materials and Methods. S-59 was then added to a final concentration of 150 μmol/L and the platelet units illuminated with 1 or 3 Joules/cm2UVA. Aliquots were withdrawn after each dose of UVA for measurement of the treated viable T-cell frequency by LDA. N = 4.

F0-151

fcontrol = control viable T-cell frequency.

F0-152

ftreated = treated viable T-cell frequency.

F0-153

The log10-reduction is calculated as log10(fcontrol/ftreated).

or Create an Account

Close Modal
Close Modal